Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680121 · ClinicalTrials.gov registry record · Phase 4
High Dose Vitamin B1 to Reduce Abusive Alcohol Use
A Phase 4 study, sponsored by University of Kansas.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT00680121 is a Phase 4 study that has completed, run by University of Kansas. The registered enrollment target is 120 participants.
The verdict
NCT00680121, a Phase 4 study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
B1AS tests the hypothesis that increased vitamin B1 (thiamine) intake can repair brain systems damaged by alcohol and help people with alcohol problems control their alcohol use. A strong, man-made form of thiamine (Benfotiamine) is used to increase blood thiamine to much higher levels than can be achieved using normal vitamin supplements. Drinking patterns are examined over 6 months of continued supplement use. Men and women with a recent history of alcohol problems are eligible to participate.
Interventions
- DRUG Placebo
- DRUG Benfotiamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680121
The ClinicalTrials.gov registry entry for NCT00680121 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00680121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680121 about?
NCT00680121 is a clinical study titled "High Dose Vitamin B1 to Reduce Abusive Alcohol Use". B1AS tests the hypothesis that increased vitamin B1 (thiamine) intake can repair brain systems damaged by alcohol and help people with alcohol problems control their alcohol use. A strong, man-made form of thiamine (Benfotiamine) is used to increase blood thiamine to much higher levels than can be a...
What is the current status of trial NCT00680121?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2008-07. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00680121?
The interventions under investigation include: Placebo (DRUG), Benfotiamine (DRUG).
Who is sponsoring clinical trial NCT00680121?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.